(Q34337056)

1 August 2017

1 reference

title

The role of biomarkers in alcoholism medication trials (English)

1 reference

1 August 2017

0 references

0 references

Allen JP

1

1 reference

1 August 2017

Litten RZ

series ordinal

2

1 reference

1 August 2017

Strid N

series ordinal

3

1 reference

1 August 2017

Sillanaukee P

series ordinal

4

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Alcoholism: Clinical and Experimental Research

1 August 2017

published in

1 reference

1 August 2017

volume

25

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

1119-1125

1 reference

The role of laboratory tests in alcoholism treatment

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

Carbohydrate-deficient transferrin: an aid to early recognition of alcohol relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

Treatment outcome in alcoholism - a comparison of self-report and the biological markers carbohydrate-deficient transferrin and gamma-glutamyl transferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.2001.TB02325.X

10.1111/J.1530-0277.2001.TB02325.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference